← Back to Clinical Trials
Recruiting NCT06635564

Personalized ViscoElastic Testing-guided Bleeding Management In Liver Surgery, Neurosurgery and Obstetrics

Trial Parameters

Condition Thrombelastography
Sponsor Medical University of Vienna
Study Type OBSERVATIONAL
Phase N/A
Enrollment 240
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-07-01
Completion 2026-04-30
Interventions
Viscoelastic testing

Brief Summary

The ClotPro analyzer is a new generation viscoelastic analyzer for the in vitro assessment of blood coagulation. This study aims to assess the agreement of ClotPro 6.0, ROTEM delta, and TEG 6s in three distinct cohorts: i) patients with liver disease undergoing liver surgery, ii) pregnant women undergoing elective cesarean section, and iii) patients undergoing elective intracranial neurosurgery. Further coagulation tests will be performed (standard laboratory coagulation tests, thrombin and plasmin generation tests) in an exploratory fashion to compare them with viscoelastic test results. The obtained test results will not result in any diagnostic or therapeutic consequences for patients included in this study.

Eligibility Criteria

Inclusion Criteria: 1. Vulnerable patient cohorts * Patients undergoing elective liver surgery defined as one of the following invasive procedures: * Liver resection (anatomic or non-anatomic segmental resection, right or left hepatectomy, right or left extended hepatectomy), * Orthotopic liver transplantation, * Pregnant women undergoing an elective caesarean section, and * Patients undergoing an elective intracranial neurosurgery. 2. Written informed consent Exclusion Criteria: none

Related Trials